Aradigm Corporation Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Financials (USD)
Sales 2016 | 195K | Sales 2017 | 14.46M | Capitalization | 97.3M |
---|---|---|---|---|---|
Net income 2016 | -32M | Net income 2017 | -10M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M | Net Debt 2017 | 7.91M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |